GABA BTA.ST Stock Analysis
GA
Uncovered
Gabather AB is uncovered by Eyestock quantitative analysis.
Gabather AB engages in the research and development of drug candidates for treatment of diseases affecting the central nervous system. The company is headquartered in Sodertalje, Stockholm. The company went IPO on 2014-11-03. The firm develops drug candidates for the treatment of several diseases originating in the central nervous system (CNS). The firm mainly focuses on anti-psychotics, anti-depressants and anxiolytics, analgesics, as well as conginition-enhancing treatments, including Alzheimer’s disease.
View Section: Eyestock Rating